Exchange: NASDAQ·Updated 05:38 AM EDT
Latest Earnings Results: Q2 '26

Reported: Aug 04

Estimated EPS

-$3.73

Reported EPS

-$3.75

Surprise

-0.67%

Estimated Rev

$170.71M

Reported Rev

$122.33M

Surprise

-28.34%

• Reported GAAP EPS of -$3.24 down -102.50% YoY • Reported revenue of $145.8M down -44.10% YoY • BioNTech is revising its full-year 2026 revenue guidance to 1.61.9 billion, while maintaining adjusted SG&A expenses at 700800 million and adjusting R&D expense guidance to 2.02.3 billion for BioNTech.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Investor Presentation6-K

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
$0.86
--
--
N/A
Q2 '26
-$3.73
-$3.75
-0.67%
MISSED
Q1 '26
-$2.57
-$2.42
5.66%
BEAT
Q4 '25
-$0.19
-$1.46
-666.92%
MISSED
Q3 '25
-$1.11
-$0.14
87.41%
BEAT

Advertisement|Remove ads.